SCHEMBL5722385

SCHEMBL5722385

CC(=O)NC[C@H]1C[C@@H](C(=O)O)C[C@@H]1N

nearest known ligand 0.63

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ SLC6A12 P48065 3/20 0.39
▸ SLC6A11 P48066 3/20 0.39
▸ SLC6A13 Q9NSD5 3/20 0.39
▸ GABRR1 P24046 1/20 0.34
▸ FUCA1 P04066 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17249604 0.89 — —
SCHEMBL5722453 0.80 KMT2A (0.32) —
SCHEMBL7230793 0.76 MTNR1A (0.34) SLC6A12SLC6A11SLC6A13
SCHEMBL22403907 0.71 SLC6A12 (0.46) SLC6A12SLC6A11SLC6A13GABRR1
SCHEMBL17249606 0.70 — —
SCHEMBL22571032 0.69 PLG (0.42) FUCA1
SCHEMBL2340454 0.69 PLG (0.42) FUCA1
SCHEMBL2340458 0.69 PLG (0.42) FUCA1
SCHEMBL2340457 0.69 PLG (0.42) FUCA1
SCHEMBL7834563 0.69 GABRR1 (0.45) GABRR1FUCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0933993-B1 SUBSTITUTED CYCLOPENTANE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS BIOCRYST PHARM INC (US) 2006-04-05 — — EP claimed
Send feedback